AVVW.OB - primed for a move up here

[FurrySound]

Broke upper B-band today, volume is up, broke and closed over 50 dma and broke down trend.

Major news yesteday about inroads into the US market. Their new distributor has over 700 dealers nationwide !!

Website: http://www.avvaa.com

Chart: http://tinyurl.com/mmakc

Share structure info:
O/S 57mil
Float 29mil

[FurrySound]

.05's going, great news out today

AVVAA WORLD HEALTH CARE PROD (U-AVVW) - News Release
avVaa World Health Care Products Introduces Private Label Program

2006-05-25 10:00 ET - News Release



LUMBY, British Columbia, May 25 /PRNewswire-FirstCall/ -- avVaa World Health Care Products, Inc. , a biotech company offering global customers therapeutic skin and health care products, announced today the launch of the Company's private label program for its human and pet skincare lines.

For its primary line of quality human skin care products, avVaa is actively seeking collaboration with drug store chains and manufacturers to provide private labeling for its NeuroSkin(TM) mild skin moisturizer, NeuroSkin spray for eczema/psoriasis relief and its NeuroSkin acne treatment. avVaa's NeuroSkin line includes high quality products that aid in the treatment of a wide variety of conditions, including: eczema, psoriasis, dermatitis, acne and rosacea. avVaa is also actively negotiating private label partnerships for its acne, burn applications and various cosmetic lines.

"Now that our high quality, therapeutic products will be actively distributed in U.S. and Canada, private labeling allows our products to benefit from immediate brand recognition and gain rapid market acceptance while providing avVaa immediate access to revenue building opportunities," said Jack Farley, CEO and chairman of avVaa World Health Care Products. "We look forward to growing our business and product lines while partnering with some of the best names in retail throughout Canada and the U.S."

avVaa is currently negotiating with a pet care product manufacturer for a private label agreement for its pet and equine dermalustre(TM) products- therapeutic, all natural skin and coat treatment for animals. avVaa is also actively seeking partnerships with retail pet care chain stores to develop private label products that benefit from avVaa's proven formulas as well as the established brand recognition and loyalty of the U.S. and Canada's most popular retailers.

For more information on private labeling opportunities with avVaa, please contact George Roadman, 508-282-1454.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.

avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC NeuroSkin(TM) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada and parts of the United States. For more information, visit: http://www.avvaa.com or http://www.otcfn.com/avvw.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

    Contact:  Merle Goertz (West Coast) of avVaa World Health Care Products,
              1-604-688-2349

                or

              Rick McCaffrey at OTC Financial Network, Investor Relations,
              781-444-6100 x625.

              Tracy Bagatelle-Black
              Mark Wachs & Associates
              661/263-1842
              [email protected]
avVaa World Health Care Products, Inc.



CONTACT: Merle Goertz - West Coast - of avVaa World Health Care Products,
+1-604-688-2349; or Rick McCaffrey, Investor Relations at OTC Financial
Network, +1-781-444-6100 x625; or Tracy Bagatelle-Black of Mark Wachs &
Associates, +1-661-263-1842, [email protected]



Web site: http://www.avvaa.com/
http://www.otcfn.com/avvw/

[FurrySound]

i've heard rumors that they are signing on walgreens, but even if it's cvs or another chain, the big chain appears to be liking and expanding the testing reach, so that's very good. (april pr)

Thinking out loud: would the company just announce a huge deal 'semi' out of the blue, or build up some audience beforehand with a few initial PR's that in and of themselves are good and then put out a huge PR... imo, they were wise to start with a few PR's before the memorial day weekend, and now that everyone is well rested and coming back to the markets, time for a big PR.

Chart: http://tinyurl.com/pm6xy

[FurrySound]

avVaa World Health Care Products Retains Leading U.S. Branding Firm to Expand Sales Channels, Including Marketing to Major TV Shopping Networks
Thursday June 8, 8:00 am ET


LUMBY, British Columbia, June 8 /PRNewswire-FirstCall/ -- avVaa World Health Care Products, Inc. (OTC Bulletin Board: AVVW - News), a biotech company offering global customers therapeutic skin and health care products, announced today that it has retained the services of International Advantage, who in association with avVaa's consultant Crossfire Network, an international sales and marketing company, are two of the nation's premier product marketing, positioning and branding firms. International Advantage retains a long-standing affiliation with one of the largest TV revenue-generating companies in the world, having brought more than 1,000 products through home shopping distribution channels. Based in Doylestown, PA, International Advantage, in conjunction with Crossfire Network, is responsible for successfully launching hundreds of consumer products that have resulted in generating total product sales in excess of $50 million since 1989.

avVaa has selected International Advantage, along with Crossfire Network, to bring the Company's primary line of personal skin care products, NeuroSkin(TM) mild skin moisturizer, NeuroSkin spray for eczema/psoriasis relief and NeuroSkin acne treatment, to new, national direct-to-consumer selling channels. avVaa's NeuroSkin line includes high quality, therapeutic products that aid in the treatment of a wide variety of conditions, including: eczema, psoriasis, dermatitis, acne and rosacea. avVaa is also actively negotiating private label partnerships for its acne, burn applications and various cosmetic lines. International Advantage and Crossfire Network will target market penetration throughout the U.S., Canada, Mexico and South America.

"The team at International Advantage knows how to successfully increase visibility and exposure for new consumer products, as well as drive impressive sales within the direct response industry. Through our partnership, and our existing relationship with Crossfire Network, we look forward to expanding our global target audience, potentially reaching millions of new end users for our therapeutic skin treatments. We anticipate International Advantage will facilitate advantageous selling channels that can create a strong, revenue-generating platform for further market penetration of our human skin care product line," said Jack Farley, CEO and chairman of avVaa World Health Care Products.

Rob Hanson, principal of International Advantage, stated, "We believe avVaa's therapeutic products address large, untapped consumer markets for treating some of the world's most common skin aliments, such as acne, eczema, and psoriasis. With our promotional and marketing support, we believe avVaa's products will be readily accepted into the North American marketplace."

About International Advantage

The principals of International Advantage collectively bring over 35 years of experience in the direct response industry, including TV infomercials/spots, radio and print advertising campaigns. Specializing in electronic packaging, promotions, selling and retailing, International Advantage has represented over 1,000 products and more than 500 vendors to the home shopping industry. The company represents both celebrity and corporate clients, and is credited with launching products, such as COLD-EEZE, into a household name.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.

avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC NeuroSkin(TM) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada and parts of the United States. For more information, visit http://www.avvaa.com.

To sign up to receive the latest news and information on avVaa World Health Care Products by email as it is disclosed, please visit: http://otcfn.com/avvw/email_update.html. Additional information for investors may be found online at http://otcfn.com/avvw/.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Contact: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349 or Rick McCaffrey at OTC Financial Network, Investor Relations, 781-444-6100 x625, [email protected]. Tracy Bagatelle-Black, Mark Wachs & Associates, 661-263-1842, [email protected].




--------------------------------------------------------------------------------
Source: avVaa World Health Care Products, Inc.

[Little Joe]

nice volume last minutes , seems to going much higher next week